885280-83-1 Usage
Uses
Used in Pharmaceutical Industry:
5-FLUORO-2,3-DIHYDRO-BENZOFURAN-3-YLAMINE HYDROCHLORIDE is used as a potential therapeutic agent for the treatment of neurological disorders due to its neuroprotective properties. It may help in safeguarding neurons from damage or degeneration, thereby offering a new avenue for managing such conditions.
Used in Oncology:
In the field of oncology, 5-FLUORO-2,3-DIHYDRO-BENZOFURAN-3-YLAMINE HYDROCHLORIDE is used as a potential antitumor agent. Its capacity to inhibit tumor growth and progression makes it a promising candidate for cancer treatment, potentially leading to the development of novel cancer therapies.
Further research is essential to fully elucidate the pharmacological properties and explore the therapeutic potential of 5-FLUORO-2,3-DIHYDRO-BENZOFURAN-3-YLAMINE HYDROCHLORIDE in these applications.
Check Digit Verification of cas no
The CAS Registry Mumber 885280-83-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,5,2,8 and 0 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 885280-83:
(8*8)+(7*8)+(6*5)+(5*2)+(4*8)+(3*0)+(2*8)+(1*3)=211
211 % 10 = 1
So 885280-83-1 is a valid CAS Registry Number.
885280-83-1Relevant articles and documents
Design and synthesis of dihydrobenzofuran amides as orally bioavailable, centrally active γ-secretase modulators
Pettersson, Martin,Johnson, Douglas S.,Subramanyam, Chakrapani,Bales, Kelly R.,Am Ende, Christopher W.,Fish, Benjamin A.,Green, Michael E.,Kauffman, Gregory W.,Lira, Ricardo,Mullins, Patrick B.,Navaratnam, Thayalan,Sakya, Subas M.,Stiff, Cory M.,Tran, Tuan P.,Vetelino, Beth C.,Xie, Longfei,Zhang, Liming,Pustilnik, Leslie R.,Wood, Kathleen M.,O'Donnell, Christopher J.
, p. 2906 - 2911 (2012/06/04)
We report the discovery and optimization of a novel series of dihydrobenzofuran amides as γ-secretase modulators (GSMs). Strategies for aligning in vitro potency with drug-like physicochemical properties and good microsomal stability while avoiding P-gp mediated efflux are discussed. Lead compounds such as 35 and 43 have moderate to good in vitro potency and excellent selectivity against Notch. Good oral bioavailability was achieved as well as robust brain Aβ42 lowering activity at 100 mg/kg po dose.